Abiopharma

Silence Therapeutics to Host Conference Call and Webcast to Discuss Topline Results from Phase 2 SANRECO Trial of Divesiran in Polycythemia Vera

Silence Therapeutics to Host Conference Call and Webcast to Discuss Topline Results from Phase 2 SANRECO Trial of Divesiran in Polycythemia Vera

NE Investors Have Opportunity to Join Noble Corporation plc Fraud Investigation with SBS Law

LMB Investors Have Opportunity to Join Limbach Holdings, Inc. Fraud Investigation with SBS Law

RadNet Reports Second Quarter Financial Results with Record Quarterly Revenue and Adjusted EBITDA(1) and Revises Upwards 2026 Financial Guidance Ranges

RadNet Reports Second Quarter Financial Results with Record Quarterly Revenue and Adjusted EBITDA(1) and Revises Upwards 2026 Financial Guidance Ranges

Invitation to a special meeting for 14.9.26 - voting ballot

Events and transactions

Ceased to be an interested party - Mor Gemel and Pension Ltd.

Ceased to be an interested party - Y.D. Mor Investments Ltd.